Abstract The object of the study was to investigate the outcome in growth-retarded newborns who were diagnosed with fetal renal hyperechogenicity without anatomical abnormality during any stage of pregnancy. Depending on the fetal renal ultrasonography result, the cases were divided into two study groups. There was an intrauterine growth-retarded group with fetal renal medullary hyperechogenicity and another group without fetal renal medullary hyperechogenicity. The renal parenchyma was observed after birth, within the first 5 days of life, and several times until the 14th postpartum day in positive cases. Hyperechogenic renal medullae were detected in 25 of 90 cases with intrauterine growth retardation during the 8-month study period. This may be an in utero cause of subsequent intrauterine and neonatal complications, such as cesarean section because of fetal distress (36%), perinatal infection (24%), treatment in a neonatal intensive care unit (52%), or increased perinatal mortality (8%). The results demonstrate that fetuses with hyperechoic medullae had 1.5 times the risk of an abnormal outcome compared with fetuses with normal echoic kidneys and intrauterine growth retardation. Detailed ultrasound examinations of renal parenchyma appear to be useful for the prenatal diagnosis of intrauterine hypoxia, allowing the detection of possible pathological fetal conditions in utero.
Introduction
The fetal and neonatal renal medulla is hypoechogenic in its normal state, so medullary hyperechogenicity is a characteristic and striking feature on ultrasound examination [1, 2, 3] . Hyperechogenicity can also be found in other diseases. According to the recent literature [4, 5, 6, 7] , hyperechogenic kidneys are due to urinary tract obstruction, polycystic and glomerulocystic kidney disease, obstructive nephrological disease, and nephrocalcinosis. In about 20% of cases with fetal renal hyperechogenicity the mechanism and diagnosis are unclear [2] .
A possible connection between intrauterine growth retardation and fetal renal medullary hyperechogenicity has not been examined to date. Hyperechogenicity of the renal cortex and especially of the renal pyramids is a well-known phenomenon; however, its importance in cases with no anatomical alteration (e.g., polycystic kidney) is controversial [2, 3, 4, 5, 7] .
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Intrauterine growth-retarded fetuses were divided into two groups: cases with (group I) and without (group II) fetal medullary hyperechogenicity. The 25 fetuses with renal medullary hyperechogenicity were compared with the remaining intrauterine growth-retarded cases (65 cases) as a control group. The clinical outcome was followed very carefully for 14 days after delivery. The results were analyzed using the odds ratio.
Results
In our study we found intrauterine growth retardation in 90 cases among the routinely scanned fetuses. We detected 25 cases with fetal medullary hyperechogenicity ( Fig.  1 ) and 65 cases without fetal medullary hyperechogenicity (group II) (Fig. 2) . Table 1 shows data of the 25 newborns (18 girls and 7 boys) with fetal medullary hyperechogenicity (group I). The mean (±SD) duration of gestation at birth was 37.5±2.2 weeks and the mean (±SD) birth weight was 2,634±741 g. The Apgar scores were 7.2±1.8 (mean±SD) at 1 min and 8.5±1.2 (mean±SD) at 5 min. We compare the two study groups in Table 2 and present the clinical outcome in Table 3 .
Cesarean section was performed in 9 cases in the hyperechogenic group (36%) and in 13 in the control group (20%). Sixteen newborns (64%) with hyperechoic medullae were transferred to the neonatal intensive care unit, while 38 cases (55%) in group II were transferred to the unit. The causes of transfer were immaturity of anatomical structures or physiological and biochemical functions, leading to inability to maintain body temperature and problems with breathing, nutrition, metabolism, immunological function, and detoxification. These pathological conditions are defined as respiratory distress syndrome, asphyxia, bradycardia, congenital malformations, repeated apnea, necrotizing enterocolitis, resuscitation, etc. [11] .
We would like to emphasize serious complications in 2 cases (Table 1 , case no.10 and no.25) in group I (cases with fetal medullary hyperechogenicity). One infant was stillborn (case no.25) at the 31st week of gestation (birth weight 420 g). One postnatal death was observed on postnatal day 2 after a cesarean section (case no.10). The intervention was indicated by pre-eclampsia, bilateral notch on the flowmetry of the uterine artery, and a pathological cardiotocography test. The newborn was premature, hypotrophic, bradycardic, and suffered from apnea, metabolic acidosis, cataract, and intraventricular hemorrhage (birth weight 950 g at the 31st week of gestation).
In group II serious complications were observed in 3 pregnancies (4.6%). One was a twin pregnancy, in which one of the fetuses died because of a heart malformation, as a result of a rubella infection. The twin sibling exhibited retarded growth only, but the clinical outcome was good. The other stillbirth in the control group was due to left ventricular hypoplasia. The third fetus with a heart malformation was born alive.
One case of multicystic kidney was diagnosed in utero in the hyperechoic group. Renal hyperechogenicity was first detected at the 18th week of gestation. Serial 577 The results were evaluated statistically using the odds ratio. Newborns with hyperechoic medullae (Fig. 3 ) had 1.5 times the risk by the odds ratio of an abnormal postnatal outcome compared with newborns with normal kidneys (Fig. 4) with intrauterine growth retardation: the odds ratio was 1.5 (1.00; 2.26); confidence interval 95%.
We used the chi-squared test for statistical analysis of birth weight abnormalities, because we expected the data to lie in a standardized range, not a fixed one (Figs. 5  and 6 ).
The result of chi-squared test was χ 2 =3.76 (P<0.05) in intrauterine growth-retarded cases with fetal renal hyperechogenicity. The difference is significant.
Discussion
Fetal and neonatal renal hyperechogenicity can be due to causes different from those in pediatric and adult patients. The possible cause of fetal and neonatal renal hyperechogenicity was first described by Estroff et al. [12] , who identified that the hyperechoic renal parenchyma in the fetus was associated with sonographic or functional abnormalities in 74% of surviving cases.
Chiara et al. [13] described the types of neonatal hyperechogenicity, i.e., diffuse, cortical, and medullary. Diffuse renal hyperechogenicity was found in cases of polycystic kidney, renal candidiasis, dysplastic kidney, and renal venous thrombosis. They observed increased cortical echogenicity in neonates with hemolytic uremic syndrome. Medullary hyperechogenicity occurred in cases of renal disease secondary to perinatal asphyxia [1, 13, 14] .
Shulman [4] summarized the possible causes of neonatal hyperechogenicity in an editorial letter. Calcium deposition, precipitation of Tamm-Horsfall proteins, crystalloids, and precipitation of other proteins or uric acid, papillary necrosis, vascular congestion, sickle cell anemia, medullary fibrosis, lymphocellular infiltration, dehydration, intrarenal reflux, and renal venous thrombosis could all have the sonographic appearance of renal hyperechogenicity [4, 14, 15] .
Neonatal medullary hyperechogenicity occurs in asphyxia, therefore we investigated this group of neonates experiencing chronic hypoxic conditions in the intrauterine and postnatal periods. We detected 25 cases of fetal renal medullary hyperechogenicity by examining 90 complicated pregnancies with intrauterine growth retardation.
In intrauterine growth-retarded fetuses there is a relationship between hypoxia and redistribution of cardiac output [9, 11] . This relationship is the part of the brain- sparing effect that has been reported in hypoxic human fetuses to induce intrauterine growth retardation. This mechanism may result in transient renal insufficiency, usually a benign disease [14] . By applying ultrasound examination, modified echogenic medullae can also be observed during the short postnatal oliguric period [1, 10] .
The renal medullary hyperechogenicity due to fetal hypoxia develops in the second or third trimester of pregnancy [8] ; in our cases between the 24th and 37th weeks of gestation. Our results show that the fetal circulation can compensate for the hypoxic state for rather a long time. This relationship is a feature of the redistribution of the cardiac output that has been reported in hypoxic human fetuses [9] . It has been noted in intrauterine growth-retarded fetuses, presumably as a result of the associated hyperechogenicity. In transient hyperechogenic cases, the cause is transient renal insufficiency [3, 10, 16, 17] . Increased echogenicity may represent a tubular blockage caused by Tamm-Horsfall protein precipitation [18] . Consistent evidence supports the idea that the transient renal insufficiency is accompanied by Tamm-Horsfall proteinuria in the postnatal period [18] .
The complication is benign if it is a transitory condition. Therefore, renal failure does not always yield tubular necrosis. The etiology and the clinical condition of acute necrosis and acute blockage of the tubules are the same. They are differentiated by the degree and the course of the disease [19, 20, 21] .
In our cases the fetal medullary echogenicity could be explained by the same mechanism, which started in intrauterine life. The Tamm-Horsfall protein blockage and increased medullary echogenicity disappears with the start of urinary production after birth [2] .
Intrauterine pathological states have ultrasonographic signs, such as oligohydramnios, decreased umbilical artery flow, etc. [22, 23] . Our study assumed that the fetal medullary hyperechogenicity was a pathological sign of an in utero hypoxic state. The medulla of the kidney is very sensitive to hypoxia and hypoxic renal failure is accompanied by hyperechogenicity of the kidneys [14] . In addition, we found that intrauterine growth retardation complicated with renal medullary hyperechogenicity suggests a more-serious pathological state.
The statistical results suggest a good relationship between this diagnostic method and the pathological clinical outcome. The odds ratio was used to analyze the association between prenatal pathological renal medullary echogenicity and pathological postnatal clinical outcome. In intrauterine growth retardation, the risk was revealed by an odds ratio of 1.5 times the normal.
We extended the ultrasonographic study over the intrauterine period and observed other consequences of chronic intrauterine hypoxia, such as retarded growth and cesarean section as the mode of delivery. There were higher rates of cesarean section because of fetal distress (12 times), perinatal infection (8 times), transfer to the neonatal intensive care unit (11 times), perinatal mortality (4.5 times), and necrotizing enterocolitis (3 times) among newborns with hyperechoic medullae than in the control group, where there was a suspected chronic hypoxic state with a normal echoic fetal kidney. Of course, these rates are much lower in the normal population.
These ultrasound signs disappear quickly after the first postnatal urinary production. In our investigations, the hyperechoic features disappeared by day 2 in 51% of cases and by the end of the 2nd week in 73% of cases. In 27%, the intrauterine renal hyperechogenicity demonstrated no ultrasonographic features. This presumed protein blockage disappeared with the start of urinary production after birth, and this was connected with the relatively rapid decrease in hyperechogenicity in the postnatal period.
Fetal renal hyperechogenicity appears to be a good predictive sign of intrauterine hypoxia. The clinical outcome supports this idea. The detection of fetal renal medullary hyperechogenicity involves a simple examination, and could therefore be performed during a routine scan. For this reason, we suggest the detection of renal echogenicity as an early sign of an intrauterine hypoxic state, since it is important to direct pregnant women to a perinatal intensive care center in order to follow the possible pathological fetal state.
It is hoped, that new means of studying fetal hypoxia -such as fetal kidney ultrasonographic investigationwill enhance our understanding of the complex issue of normal and abnormal development during pregnancy. Uteroglobin gene-disrupted mice develop a nephritis very similar to immunoglobulin A (IgA) nephropathy. Megsin codes for a protein overexpressed in mesangium in patients with IgA nephropathy. Both are candidate genes that might have variants associated with an accelerated progression in patients with IgA nephropathy. We performed an association study of patients with IgA nephropathy and matching control subjects to test whether the G38A polymorphism in the uteroglobin gene, the C2093T polymorphism in the megsin gene, or the angiotensin-converting enzyme (ACE) insertion/deletion polymorphism is associated with IgA nephropathy or rate of disease progression in patients with IgA nephropathy. Of 110 patients with IgA nephropathy, 87 patients were followed up for at least 3 years for the progression study. We also studied 104 healthy volunteers. The uteroglobin, megsin, and ACE polymorphisms were not distributed differently in the 110 patients with IgA nephropathy compared with healthy controls; HardyWeinberg equilibrium criteria were fulfilled. The GG genotype of the G38A uteroglobin polymorphism was more common in patients with progression (odds ratio [OR], 3.5; P<0.006) than the AG+AA genotypes. The G allele was also more common (OR, 2.6; P<0.009) in patients with versus without progression. The 1/serum creatinine over time plot (in deciliters per milligram per day) was sevenfold steeper in GG patients than the other two genotypes (P=0.08). No significant associations with disease progression were found for the other gene polymorphisms, and a multivariate analysis showed no interactions. We suggest the hypothesis that the uteroglobin gene contains variant(s) with a bearing on progression rate in patients with IgA nephropathy. Background We have previously demonstrated an essential role for increased epidermal growth factor receptor (EGFR) activity in mediating renal cyst formation and biliary epithelial hyperplasia in murine models of autosomal recessive polycystic kidney disease (ARPKD). This study was designed to determine whether or not treatment with a newly developed inhibitor of EGFR tyrosine kinase activity (EKI-785) would reduce renal and biliary abnormalities in murine ARPKD. Methods Balb/c-bpk/bpk (BPK) litters were treated with EKI-785, an EGFR-specific tyrosine kinase inhibitor. Animals were treated by intraperitoneal injection beginning at postnatal day 7 and were treated until postnatal day 24 or 48. EKI-785's effectiveness was measured by a reduction in the renal cystic index, an increased life span, and maintenance of normal renal function. Results Treatment of BPK mice with EKI-785 resulted in a marked reduction of collecting tubule (CT) cystic lesions, improved renal function, decreased biliary epithelial abnormalities, and an increased life span. Untreated cystic animals died of renal failure at postnatal day 24 (P-24) with a CT cystic index of 4.8, a maximal urine osmolarity of 361 mOsm, and moderate to severe biliary abnormalities. Cystic animals treated with EKI-785 to postnatal day 48 (P-48) were alive and well with normal renal function, a reduced CT cystic index of 2.0 (P<0.02), a threefold increased in maximum urinary concentrating ability (P<0.01), and a significant decrease in biliary epithelial proliferation/fibrosis (P<0.01). Conclusion This study demonstrates that EKI-785 has therapeutic effectiveness in improving histopathologic abnormalities and decreasing mortality in murine ARPKD.
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